Zobrazeno 1 - 10
of 1 066
pro vyhledávání: '"Jawa V"'
Autor:
Cohen JR; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA. jcohen02@amgen.com., Brych SR; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Prabhu S; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Bi V; The Department of Biosimilars, Amgen Inc, Thousand Oaks, CA, 91320, USA., Elbaradei A; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Tokuda JM; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Xiang C; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Hokom M; The Department of Clinical Immunology, Amgen Inc, Thousand Oaks, CA, 91320, USA.; Department of BioAnalytical Sciences, Genentech, Inc, South San Francisco, CA, 94080, USA., Cui X; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Ly C; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Amos N; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Sun J; Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, 91320, USA., Calamba D; Translational Safety and Bioanalytical Sciences, Amgen Inc, Thousand Oaks, CA, 91320, USA., Herskovitz J; The Department of Clinical Immunology, Amgen Inc, Thousand Oaks, CA, 91320, USA.; Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68198, USA., Capili A; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Nourbakhsh K; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Merlo A; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Carreon J; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Wypych J; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Narhi LO; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA., Jawa V; The Department of Clinical Immunology, Amgen Inc, Thousand Oaks, CA, 91320, USA.; Department of Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb, Princeton, NJ, 08543, USA., Joubert MK; The Department of Process Development, Amgen Inc, One Amgen Center Dr, Thousand Oaks, CA, 91320, USA. mjoubert@amgen.com.
Publikováno v:
Pharmaceutical research [Pharm Res] 2024 Apr; Vol. 41 (4), pp. 651-672. Date of Electronic Publication: 2024 Mar 22.
Autor:
Bárta, Karel
The purpose of this disertation is to capture the era of so-called normalisation during the 1970s and 1980s of the 20th century in Czechoslovakia. Even though the economic transformation in the 1990s is covered, the normalisation is in this case the
Externí odkaz:
http://www.nusl.cz/ntk/nusl-353152
Autor:
Dai Y; Translational Medicine, Bristol Myers Squibb Company, Princeton, NJ 08543, United States. Electronic address: Yanshan.dai@bms.com., Adusumilli A; Translational Medicine, Bristol Myers Squibb Company, Princeton, NJ 08543, United States., Adeel F; Translational Medicine, Bristol Myers Squibb Company, Princeton, NJ 08543, United States., Kozhich A; Translational Medicine, Bristol Myers Squibb Company, Princeton, NJ 08543, United States., Jawa V; Translational Medicine, Bristol Myers Squibb Company, Princeton, NJ 08543, United States.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.
Autor:
Tirto Suwondo
This article was written to welcome the implementation of the 5th Java Language Congress in Surabaya 2011. There are four points suggested in this article: (1) there should be an evaluation of the congress decision, (2) there should be an accountabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7276a9efd84f16dcbc7c7667d787712d
Autor:
Nagaraja Shastri P; Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine, Spring House, Pennsylvania, USA., Shah N; Clinical Pharmacology and Pharmacometrics, Johnson and Johnson Innovative Medicine, Spring House, Pennsylvania, USA., Lechmann M; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Penzberg, Germany., Mody H; Clinical Pharmacology, Genentech, South San Francisco, California, USA., Retter MW; Preclinical PK/PD, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Zhu M; Clinical Pharmacology, Regeneron Pharmaceuticals, Tarrytown, New York, USA., Li T; Clinical Pharmacology, Genmab, Plainsboro, New Jersey, USA., Wang J; Biotherapeutics Discovery Research, Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, Connecticut, USA., Shaik N; Clinical Pharmacology, Pfizer Oncology Development, San Diego, California, USA., Zheng X; Clinical Pharmacology, Pharmacometrics and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Ovacik M; Preclinical PK/PD, Genentech, South San Francisco, California, USA., Hua F; Certara Predictive Technology, Certara, Concord, Massachusetts, USA., Jawa V; Clinical Pharmacology, Pharmacometrics and Bioanalysis, Bristol Myers Squibb, Princeton, New Jersey, USA., Boetsch C; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Burke J; Certara Predictive Technology, Certara, Concord, Massachusetts, USA., Datta K; Nonclinical Safety, Bristol Myers Squibb, Princeton, New Jersey, USA., Gadkar K; Preclinical PK/PD, Genentech, South San Francisco, California, USA., Upreti V; Clinical Pharmacology, Modeling & Simulation, Amgen, South San Francisco, California, USA., Betts A; Preclinical & Translational Sciences, Takeda Pharmaceutical Company Limited, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Sep 19. Date of Electronic Publication: 2024 Sep 19.
Autor:
Dai Y; Clinical Pharmacology, Pharmacometrics, & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA. Yanshan.dai@bms.com., Wu X; Clinical Pharmacology, Pharmacometrics, & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Sun X; Translational Sciences and Diagnostics, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Cohen D; Protein Sciences, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Rajeswaran D; Protein Sciences, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Robotham S; Translational Sciences and Diagnostics, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Chilewski S; Translational Sciences and Diagnostics, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Yang K; Clinical Pharmacology, Pharmacometrics, & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Yearwood G; Translational Sciences and Diagnostics, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Kozhich A; Clinical Pharmacology, Pharmacometrics, & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Jawa V; Clinical Pharmacology, Pharmacometrics, & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA.
Publikováno v:
The AAPS journal [AAPS J] 2024 Sep 16; Vol. 26 (6), pp. 104. Date of Electronic Publication: 2024 Sep 16.
Autor:
Gopallawa I; Clinical Pharmacology & Safety Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, USA., Gupta C; The Jackson Laboratory, Bar Harbor, ME, USA., Jawa R; University of Pennsylvania, Philadelphia, PA, USA., Cyril A; Department of Psychology, University of California at Los Angeles, Los Angeles, CA, USA., Jawa V; Bristol Myers Squibb, Lawrenceville, NY, USA. Electronic address: Vibha.Jawa@bms.com., Chirmule N; SymphonyTech Biologics, Philadelphia, PA, USA. Electronic address: Narendra.Chirmule@symphonytech.com., Gujar V; Anatomy and Cell Biology, Oklahoma State University Center for Health Sciences, Tulsa, OK, USA.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Sep; Vol. 113 (9), pp. 2659-2667. Date of Electronic Publication: 2024 Jul 20.
Autor:
Mora J; Clinical Pharmacology Pharmacometrics and Bioanalysis, Bristol Myers Squibb, Princeton, NJ, United States. Electronic address: johanna.mora@bms.com., Forman D; Discovery Biotherapeutics, Bristol Myers Squibb, Cambridge MA, United States., Hu J; Current: Technical Operations, Analytical Development, Gentibio, Seattle, WA, United States., Ijantkar A; Cell Therapy Product and Analytical Development, Bristol Myers Squibb, Seattle, WA, United States., Gokemeijer J; Discovery Biotherapeutics, Bristol Myers Squibb, Cambridge MA, United States., Kolaja KL; Nonclincial Safety, Bristol Meyers Squibb, Summit NJ, United States., Picarillo C; Discovery Biotherapeutics, Bristol Myers Squibb, Cambridge MA, United States., Jawa V; Clinical Pharmacology Pharmacometrics and Bioanalysis, Bristol Myers Squibb, Princeton, NJ, United States., Yue H; Cell Therapy Product and Analytical Development, Bristol Myers Squibb, Seattle, WA, United States., Lamy J; ImmunXperts, a Q2 Solutions Company, Gosselies, Belgium., Denies S; ImmunXperts, a Q2 Solutions Company, Gosselies, Belgium., Schockaert J; ImmunXperts, a Q2 Solutions Company, Gosselies, Belgium., Ackaert C; ImmunXperts, a Q2 Solutions Company, Gosselies, Belgium.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2024 Aug; Vol. 113 (8), pp. 2151-2160. Date of Electronic Publication: 2024 May 18.
Autor:
Gokemeijer J; Bristol Myers Squibb, 100 Binney Street, Cambridge, Massachusetts, 02143, USA. jochem.gokemeijer@bms.com., Wen Y; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, USA., Jawa V; Bristol Myers Squibb, Lawrenceville, New Jersey, 08540, USA., Mitra-Kaushik S; Takeda Pharmaceuticals, 300 Massachusetts Ave, Cambridge, Massachusetts, 02139, USA., Chung S; Genentech Inc., South San Francisco, California, 94080, USA., Goggins A; Merck & Co., Inc., South San Francisco, California, 94080, USA., Kumar S; EMD Serono Research & Development Institute, (A Business of Merck KGaA, Darmstadt, Germany), Billerica, Massachusetts, 01826, USA., Lamberth K; Novo Nordisk A/S, Maaloev, Denmark., Liao K; Merck & Co., Inc., West Point, Pennsylvania, 19486, USA., Lill J; Genentech Inc., South San Francisco, California, 94080, USA., Phung Q; Genentech Inc., South San Francisco, California, 94080, USA., Walsh R; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, USA., Roberts BJ; EpiVax, Providence, Rhode Island, 02909, USA., Swanson M; Janssen R&D LLC., 1400 McKean Road, Spring House, Pennsylvania, 19477, USA., Singh I; Spark Therapeutics, Philadelphia, Pennsylvania, USA., Tourdot S; BioMedicine Design, Pfizer Inc., Andover, Massachusetts, 01810, USA., Kroenke MA; Clinical Immunology, Amgen, Thousand Oaks, California, 91320, USA., Rup B; Bonnie Rup Consulting, LLC, 42 Commonwealth Ave, Boston, Massachusetts, 02116, USA., Goletz TJ; GlaxoSmithKline, Rockville, Maryland, 20850, USA., Gupta S; AbbVie, Irvine, California, 92612, USA., Malherbe L; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, 46285, USA., Pattijn S; ImmunXperts, 6041, Charleroi, Belgium.
Publikováno v:
The AAPS journal [AAPS J] 2023 Jun 02; Vol. 25 (4), pp. 55. Date of Electronic Publication: 2023 Jun 02.
Autor:
Dai Y; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA. Yanshan.dai@bms.com., Dong H; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Gleason C; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Mora J; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Kolaitis G; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Balasubramanian N; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Surapaneni S; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Kozhich A; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA., Jawa V; Clinical Pharmacology, Pharmacometrics, Disposition & Bioanalysis, Bristol Myers Squibb Company, Princeton, New Jersey, 08543, USA.
Publikováno v:
The AAPS journal [AAPS J] 2023 Apr 03; Vol. 25 (3), pp. 35. Date of Electronic Publication: 2023 Apr 03.